SHULAMIT LEVENBERG, Haifa (Israel)
Talk Title: Imaging 3D vascularized engineered tissue constructs
Head of the Stem Cell and Tissue Engineering Laboratory, Faculty of Biomedical Engineering at Technion, Israel Institute of Technology
Prof. Shulamit Levenberg is the former Dean of the Biomedical Engineering Department at the Technion. She currently serves as the director of the Technion Center for 3D Bioprinting and The Rina & Avner Schneur Center for Diabetes Research.
Shulamit conducts interdisciplinary research on stem cells and tissue engineering. She has received numerous prizes including the Krill Prize for excellence in scientific research, awarded by the Wolf Foundation, and was named by Scientific American as a “Research Leader” in tissue engineering, for her seminal work on vascularization of engineered tissues. She has also received the Rappaport Prize for Excellence in Biomedical Sciences and a Medal of Distinction from the Peres Center for Peace and Innovation.
Shulamit Levenberg has authored over 150 publications, and presented her work as an invited lecturer in over 150 international conferences.
She is founder and CSO of three start-up companies in the areas of cultured meat, spinal cord regeneration and nanoliter arrays for rapid antimicrobial susceptibility testing.
Shulamit earned a PhD at the Weizmann Institute of Science, where she focused on cell adhesion dynamics and signaling, and pursued her post-doctoral research in tissue engineering at MIT, in the lab of Professor Robert Langer. She spent a year as a visiting professor at the Wyss Institute for Biology Inspired Engineering at Harvard University.
KULLERVO HYNYNEN, Toronto (Canada)
Talk Title: MRI-guided focused ultrasound for targeted drug delivery and gene therapy
Vice-President, Research and Innovation, Director focused ultrasound (FUS) group at Sunnybrook Research Institute in Toronto, Canada
Prof. Kullervo Hynynen’s research has focused on studying the effects of ultrasound beams on tissue and their utilization in therapy. He is investigating the use of focused ultrasound for noninvasive surgery, vascular surgery, targeted drug delivery and gene therapy.
He has developed theoretical models to help understand treatment parameters and to allow optimization of treatment devices. Kullervo has conducted in vivo experiments to investigate the various biological end points that can be induced by controlling the sonication parameters.
His research on ultrasound transducers has been used to design and develop new phased array applicators and better ways to deliver therapy. He is also looking at the use of magnetic resonance imaging to detect and quantify noninvasive ultrasound exposure in vivo.
Kullervo has developed several systems that are being tested clinically. He is currently exploring new ways to utilize ultrasound for imaging with the aim of using the methods for controlling delivery of therapy and aid in tumour diagnosis.
JOSEPH MORAN, Strasbourg (France)
Talk Title: The Metabolic Origin of Life
Director Laboratory of Chemical Catalysis at University of Strasbourg, France
Prof. Joseph Moran is professor at University of Strasbourg. He is a synthetic organic chemist interested in catalysis in complex systems and the origin of biological metabolism.
His research applies concepts from systems and supramolecular chemistry to catalysis and the chemical origins of life. His work has shed light on how metabolism may have arisen in prebiotic waters before the onset of Darwinian evolution.
He leads a young research group in Strasbourg that is applying systems and supramolecular ways of thinking to solve problems in catalysis and the chemical origins of life.
MICHELLE BRADBURY, New York (USA)
Talk Title: New Frontiers and Emerging Nanomaterials for Advancing Image-Guided Perioperative Cancer Care and Drug Delivery
Director, Molecular Imaging Institute & Perioperative Imaging & Engineered Technologies for Oncology at Cornell Institute for Engineering Innovations in Medicine in New York
Prof. Michelle Bradbury is Professor of Radiology and Endowed Professor of Imaging Research.
Michelle specializes in nanomedicine and molecular imaging / radiological sciences and led the successful clinical translation of C-Dots. She has amassed an impressive array of patents, publications, and research grants, in addition to receiving numerous recognitions. Michelle is an active leader in the nanotechnology community and has been named to several national and international nanomedicine boards.
- 10 Oct. 2023 | Opening Abstract Submission
- 21 Nov. 2023 | Deadline Abstract Submission
- 4 Jan. 2024 | Notification to Presenters
- 17 Jan. 2024 | Early Bird Registration Deadline